Tag Archives: Cancer

The Future of Cancer Care?

Human behavior may be the most significant variable in the future of cancer care in two senses: a). The “front-end” or “topographical changes” affecting the identification of need and potential treatment modalities; and b). The care “system” delivery/payment models for care. It will not be about the technology or some great pharmaceutical breakthrough, at least […]
Posted in Guest Blog, healthcare | Also tagged | Leave a comment

After Delays, Project DataSphere Rolls Out

An industry and academic data-sharing project went live on Tuesday, nearly a year after the platform was expected to launch. Visitors to the site – no credentials needed – can register and access de-identified clinical data from the comparator arms of nine oncology trials, with more to come. Project DataSphere, the newest data transparency and […]
Posted in Biotech, Corporate Responsibility, Europe, FDA, Global, IP, leadership, Legal, R&D, Strategy, Technology | Also tagged , , , , , , , , | Leave a comment

Six Steps to Better Cancer Care in Europe

A  report published yesterday provides recommendations for combating the “significant inequalities” affecting access to quality cancer care in Europe.
Posted in Europe, healthcare | Also tagged , , | Leave a comment

Casing Cancer: ASCO Launches New Series on State of the Disease

Despite its importance as a vital indicator of overall population health status, cancer suffers from an information deficit – particularly when considered from a global perspective. The American Society of Clinical Oncology [ASCO], the lead professional group in this space, is now working to rectify at least part of the gap with the launch of […]
Posted in healthcare, leadership, Market Access, pricing, R&D, Regulatory, Safety, Strategy | Also tagged , , , , | Leave a comment

CEO Interview: Harvey Berger, Ariad Pharmaceuticals

Eight months into the launch of its first approved drug – Iclusig (ponatinib), a small molecule therapy indicated for two rare forms of leukemia – Ariad Pharmaceuticals’ principal founder and CEO Harvey Berger says doing it all, from discovery to global commercialization, is the company’s path to sustainability and the way to take on Big […]
Posted in Biotech, Europe, Gene therapy, Global, leadership, Market Access, Marketing, pricing, R&D, Regulatory, Safety, Sales, Strategy, Technology | Also tagged , , , , , , , , | Leave a comment
  • Categories

  • Meta